NCT06988865

Benign Migratory Glossitis Associated With Antiangiogenic Drugs

Benign Migratory Glossitis Associated With Antiangiogenic Drugs Used in Cancer Treatment

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 8 (actual)
• Sponsor: Instituto do Cancer do Estado de São Paulo · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

Oral clinical descriptions related to adverse events in patients treated with those elective multi-targeted receptor tyrosine kinase inhibitors and a recombinant humanised monoclonal antibody

Detailed description

Electronical medical and dental records, high-resolution digital photograph were reviewed. Demographic data, medical background, clinical and laboratory information were recorded for each individual case.

Conditions

• Cancer
• Geographic Tongue

Interventions

Type	Name	Description
OTHER	Clinical evaluation	treatment methods, associated symptoms, evolution and clinical presentation

Timeline

• Start date: 2017-07-16
• Primary completion: 2020-01-10
• Completion: 2024-02-01
• First posted: 2025-05-25
• Last updated: 2025-05-25

Locations

1 site across 1 country: Brazil